Biotinylated Human CNR1 Protein, Flag Tag&His,Avitag™ (Detergent)

ユーザーレビュー
製品番号/仕様
価格
数量
CN1-H85D3-20ug
$1240.00
CN1-H85D3-100ug
$3400.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    CNR1, cannabinoid receptor 1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR

  • Source

    Detergent Biotinylated Human CNR1 Protein, Flag Tag&His,Avitag (CN1-H85D3) is expressed from Baculovirus-Insect cells. It contains AA Gly 99 - Ala 301 & Asp 333 - Ser 414 (Accession # P21554-1).

    Predicted N-terminus: Asp

    Request for sequence
  • Molecular Characterization

    This protein carries a Flag tag at the N-terminus and a polyhistidine tag at the C-terminus followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 60.3 kDa. The protein migrates as 43-45 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    Within the expressed region, several mutations were introduced to optimize the protein expression and stability.

    *The detergent Buffer B (Cat. No. LG-13) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >85% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of detergent.
    Detergent buffer is INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove detergent.
    Detergent buffer is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, Buffer B, pH7.5, CHS with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    CNR1 SDS-PAGE

    Biotinylated Human CNR1 Protein, Flag Tag&His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 85% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     CNR1 ELISA

    Immobilized Biotinylated Human CNR1 Protein, Flag Tag&His,Avitag (Cat. No. CN1-H85D3) at 5 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-CNR1 Antibody, Human IgG4 with a linear range of 0.02-3 ng/mL (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

The Cannabinoid Receptor 1 (CB1), a CNS-abundant GPCR mediating psychoactive effects of THC and regulating appetite, pain, and mood. Peripheral CB1 inverse agonism is a promising strategy for treating metabolic syndrome and liver fibrosis, aiming to recapitulate metabolic benefits without the CNS side effects of rimonabant.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Cannabinoid CB1 receptor

  • カテゴリ:

  • 市販の医薬品数:

    2 詳細

  • 治験医薬品数:

    38 詳細

  • 最新の開発ステージ:

    Approved

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8